Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2013-05-29 | Randy Hill was appointed a director in April 2013. Mr. Hill joined the Company as Senior Vice President of Vasomedical and Chief Executive Officer of Vaso Diagnostics, Inc. d/b/a/ VasoHealthcare, a wholly owned subsidiary of Vasomedical, on July 30, 2012. No specific director compensation listed for Randy Hill. |
| 2014-04-10 | Randy Hill was appointed a director in April 2013. Mr. Hill joined the Company as Senior Vice President of Vasomedical and Chief Executive Officer of Vaso Diagnostics, Inc. d/b/a/ VasoHealthcare, a wholly owned subsidiary of Vasomedical, on July 30, 2012. Non-employee directors receive an annual fee of $30,000, payable in stock or cash. In addition, each non-employee director receives a fee of $2,500 for each Board meeting attended in person, $2,500 for each Audit Committee meeting attended, $1,500 for each Compensation Committee meeting attended, and $1,500 for each Executive Committee meeting attended. Each director that serves as the Chair of a committee of the Board receives an annual fee of $5,000 in addition to the other fees to which they are entitled. The Company also reimburses directors for reasonable expenses incurred in attending meetings. The table below summarizes compensation paid in the year ended December 31, 2013 by the Company to its directors: Randy Hill: $18,000. |
| 2015-04-28 | Randy Hill was appointed a director in April 2013. No compensation was reported for Randy Hill in 2014. |
| 2016-09-23 | Randy Hill joined the Company as Senior Vice President of Vasomedical and Chief Executive Officer of VasoHealthcare on July 30, 2012 and served in that position through December 31, 2015. He is currently Chairman of our subsidiary, VasoHealthcare and a Consultant to the Company. |
| 2017-09-01 | Randy Hill Fees Earned or Paid in Cash: 40,000 Stock Awards: 24,000 All Other Compensation: 63,012 Total: 127,012 |
Data sourced from SEC filings. Last updated: 2026-02-03